Market Cap: $888.39M
LI
Lexicon Pharmaceuticals, Inc.
LXRX
NASDAQ (NASDAQ Global Select)USD
Market Cap: $888.39M
Analysts estimated LXRX earnings of $-0.05 per share this quarter (Q2). LXRX's actual earnings were $-0.07 per share.
LXRX EPS surprise of -36.72%Analysts estimated LXRX earnings of $-0.07 per share this quarter (Q4). LXRX's actual earnings were $-0.04 per share.
LXRX EPS surprise of 43.18%Analysts estimated LXRX earnings of $-0.07 per share this quarter (Q3). LXRX's actual earnings were $-0.04 per share.
LXRX EPS surprise of 40.56%Analysts estimated LXRX earnings of $-0.08 per share this quarter (Q2). LXRX's actual earnings were $0.01 per share.
LXRX EPS surprise of 112.64%Analysts estimated LXRX earnings of $-0.10 per share this quarter (Q1). LXRX's actual earnings were $-0.07 per share.
LXRX EPS surprise of 29.65%Analysts estimated LXRX earnings of $-0.13 per share this quarter (Q4). LXRX's actual earnings were $-0.09 per share.
LXRX EPS surprise of 30.72%Analysts estimated LXRX earnings of $-0.17 per share this quarter (Q3). LXRX's actual earnings were $-0.18 per share.
LXRX EPS surprise of -7.27%Analysts estimated LXRX earnings of $-0.19 per share this quarter (Q2). LXRX's actual earnings were $-0.17 per share.
LXRX EPS surprise of 11.64%Analysts estimated LXRX earnings of $-0.22 per share this quarter (Q3). LXRX's actual earnings were $-0.21 per share.
LXRX EPS surprise of -4.11%Analysts estimated LXRX earnings of $-0.22 per share this quarter (Q3). LXRX's actual earnings were $-0.21 per share.
LXRX EPS surprise of -4.11%